Loading data
PLRXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0 USD | 0 USD | 1.58 m USD | 9.69 m USD | 7.57 m USD |
| Research and development expense | 109.16 m USD | 169.31 m USD | 127.8 m USD | 96.94 m USD | 77.55 m USD |
| Operating profit | -156.37 m USD | -228.37 m USD | -184.15 m USD | -127.2 m USD | -97.54 m USD |
| Interest expense | — | — | 1.27 m USD | 791 k USD | 0 USD |
| Income tax expense | 0 USD | — | — | — | — |
| Net income (reported basis) | 149.3 m USD | 210.3 m USD | 161.3 m USD | 123.3 m USD | 97.3 m USD |
| Net income attributable to common shareholders | — | — | — | -123.32 m USD | -97.26 m USD |
| Basic earnings per share | -2.43 USD/share | -3.47 USD/share | -2.75 USD/share | -2.94 USD/share | -2.71 USD/share |
| Diluted earnings per share | -2.43 USD/share | -3.47 USD/share | -2.75 USD/share | -2.94 USD/share | -2.71 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.